Complete Antenatal Screening Profile at Dr. Essa Lab

Antenatal Screening at Dr. Essa Lab

Antenatal screening is a cornerstone of comprehensive prenatal care, designed to safeguard the health of both the expectant mother and her developing fetus. At Dr. Essa Laboratory & Diagnostic Centre, we offer a highly sophisticated Antenatal Screening Profile that integrates multiple essential laboratory investigations into a single, streamlined assessment. This screening is typically performed during the first trimester of pregnancy, serving as an early diagnostic baseline to identify potential maternal health risks, infectious diseases, and genetic or hematological incompatibilities that could impact fetal development.

The screening works by analyzing maternal blood and urine samples using advanced diagnostic technologies. Our state-of-the-art clinical pathology department in Karachi utilizes fully automated hematology analyzers, chemiluminescence immunoassay (CLIA) platforms, and high-throughput biochemistry systems to deliver exceptionally precise results. The primary anatomical and physiological systems evaluated include the maternal hematopoietic system (red blood cells, white blood cells, and platelets), metabolic and endocrine health (blood glucose and thyroid function), immune status, and renal function.

The clinical importance of antenatal screening cannot be overstated. By establishing a comprehensive health profile early in pregnancy, obstetricians and maternal-fetal medicine specialists can proactively manage conditions such as gestational diabetes, maternal anemia, thyroid disorders, and asymptomatic urinary tract infections. Furthermore, identifying maternal blood group compatibility and screening for transmissible infections like Hepatitis B, Hepatitis C, HIV, and Syphilis allows for timely medical interventions that significantly reduce the risk of vertical transmission to the fetus. Choosing Dr. Essa Lab for your antenatal screening ensures access to internationally recognized diagnostic standards, highly experienced pathologists, and rapid, reliable reporting.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest accuracy of your Antenatal Screening results, please adhere to the following preparation guidelines:

• Fasting: A fasting period of 8 to 12 hours is generally required before sample collection, as the profile includes fasting blood glucose and lipid evaluations. You may drink plain water during this period to stay hydrated.
• Medication Disclosure: Inform your healthcare provider and the laboratory staff about any medications, prenatal vitamins, iron supplements, or hormonal therapies you are currently taking.
• Hydration: Drink adequate amounts of water before your visit. Good hydration makes venipuncture easier and ensures a sufficient urine sample.
• Urine Sample Collection: You will be provided with a sterile container for a midstream clean-catch urine specimen. It is best to collect the first morning urine if possible, or ensure the genital area is cleansed prior to collection to avoid contamination.
• Timing: Schedule your test during the early morning hours to accommodate fasting requirements and ensure prompt processing of samples.

During the Procedure

The clinical procedure for antenatal screening at Dr. Essa Lab is safe, sterile, and highly efficient, taking approximately 15 to 20 minutes in total:

• Patient Positioning: You will be comfortably seated in a specialized phlebotomy chair. The phlebotomist will ask you to extend your arm and rest it on a supportive cushion.
• Site Selection and Preparation: The phlebotomist will locate a suitable vein, typically in the antecubital fossa (inner elbow). The skin over the selected vein is thoroughly disinfected using an alcohol swab.
• Venipuncture: A sterile, single-use, fine-gauge needle is inserted into the vein to collect the required blood volume into multiple color-coded vacuum tubes (EDTA, serum separator, and fluoride tubes). You may feel a brief, mild pinch during insertion.
• Hemostasis: After removing the needle, gentle pressure is applied to the puncture site with a sterile cotton ball, followed by the application of a hypoallergenic adhesive bandage to prevent bruising.
• Urine Collection: You will be directed to the restroom to collect a midstream urine sample in the sterile container provided.
• Safety and Comfort: Our phlebotomists adhere to strict infection control protocols, including hand hygiene and the use of fresh gloves for every patient. If you have a history of dizziness or fainting during blood draws, please inform our staff beforehand so we can perform the procedure in a recumbent position.

When is an Antenatal Screening Performed?

Routine First Trimester Evaluation

Obstetricians routinely recommend comprehensive antenatal screening during the first prenatal visit, ideally within the first 8 to 12 weeks of gestation. This baseline assessment is critical for establishing the mother’s overall health status at the onset of pregnancy. It allows clinicians to identify pre-existing, often asymptomatic conditions that could be exacerbated by the physiological demands of pregnancy. Early detection ensures that personalized prenatal care plans, dietary modifications, and medical therapies can be implemented immediately to support a healthy gestational period.

Screening for Gestational Diabetes Mellitus

Gestational diabetes mellitus (GDM) poses significant risks to both mother and fetus, including macrosomia, birth trauma, and neonatal hypoglycemia. Antenatal screening evaluates blood glucose levels early in pregnancy to detect pre-existing undiagnosed diabetes or early-onset glucose intolerance. Identifying metabolic dysfunction early allows healthcare providers to implement nutritional counseling, lifestyle interventions, or insulin therapy promptly, minimizing maternal-fetal complications and ensuring optimal glycemic control throughout gestation.

Identification of Maternal Anemia and Nutritional Deficiencies

Maternal anemia, primarily caused by iron deficiency, is a highly prevalent condition that can lead to intrauterine growth restriction (IUGR), preterm birth, and low birth weight. The complete blood count (CBC) component of the antenatal screening measures hemoglobin levels, hematocrit, and red blood cell indices. Detecting anemia early enables timely iron supplementation and dietary interventions, preventing maternal fatigue, reducing the risk of postpartum hemorrhage, and supporting the increased oxygen demands of the developing fetus and placenta.

Prevention of Mother-to-Child Infectious Disease Transmission

Screening for infectious agents such as Hepatitis B (HBsAg), Hepatitis C (Anti-HCV), HIV, and Syphilis (VDRL) is a vital component of antenatal care. These infections can be transmitted vertically from mother to child during pregnancy, labor, or breastfeeding, leading to severe congenital anomalies, neonatal infections, or chronic health conditions. Early identification allows for immediate prophylactic interventions, such as antiviral therapies, immunizations at birth, or planned cesarean delivery, drastically reducing transmission rates and protecting neonatal health.

Assessment of Rh Incompatibility and Blood Grouping

Determining the mother’s ABO blood group and Rh factor is essential to identify the risk of Rh incompatibility. If an Rh-negative mother carries an Rh-positive fetus, maternal exposure to fetal red blood cells can trigger the production of anti-Rh antibodies. In subsequent pregnancies, these antibodies can cross the placenta and destroy fetal red blood cells, causing hemolytic disease of the newborn (HDN). Antenatal screening identifies at-risk mothers early, allowing for the timely administration of Rh immunoglobulin (RhoGAM) to prevent sensitization.

What Does an Antenatal Screening Detect?

The comprehensive Antenatal Screening Profile at Dr. Essa Lab is designed to detect a wide array of clinical conditions, physiological imbalances, and infectious diseases, including:

• Iron deficiency anemia: Characterized by low hemoglobin and microcytic, hypochromic red blood cells.
• Megaloblastic anemia: Associated with vitamin B12 or folate deficiency, showing macrocytic red blood cells.
• Gestational diabetes: Or pre-existing impaired glucose tolerance.
• Rh incompatibility risk: Rh-negative maternal blood status.
• Maternal blood group: ABO system for transfusion compatibility and neonatal jaundice risk.
• Active Hepatitis B infection: Positive HBsAg requiring neonatal immunoprophylaxis.
• Hepatitis C infection: Positive Anti-HCV requiring specialized maternal-fetal monitoring.
• Human Immunodeficiency Virus (HIV I & II) infection: Allowing for highly active antiretroviral therapy (HAART) to prevent vertical transmission.
• Syphilis infection: Reactive VDRL/RPR, which can cause congenital syphilis, miscarriage, or stillbirth if untreated.
• Rubella immunity status: Maternal Rubella IgG antibodies, identifying susceptibility to congenital rubella syndrome.
• Asymptomatic bacteriuria: Presence of significant bacteria in urine, which can progress to acute pyelonephritis.
• Proteinuria: Elevated protein in urine, a key diagnostic marker for pre-eclampsia when combined with hypertension.
• Glucosuria: Glucose in urine, indicating potential renal threshold bypass or poorly controlled diabetes.
• Hematuria: Red blood cells in urine, suggesting urinary tract infections, renal calculi, or glomerulonephritis.
• Leukocyturia and nitrituria: Indicating active urinary tract infection (UTI).
• Thrombocytopenia: Low platelet count, which can impact blood clotting during delivery (e.g., gestational thrombocytopenia or immune thrombocytopenia).
• Leukocytosis: Elevated white blood cell count, indicating systemic infection or acute inflammatory response.
• Subclinical or clinical hypothyroidism: Elevated TSH, which can impair fetal cognitive development.
• Hyperthyroidism: Suppressed TSH, which increases the risk of pre-eclampsia, thyroid storm, and low birth weight.
• Hemoglobinopathies: Such as Thalassemia minor or sickle cell trait through abnormal red blood cell indices, prompting hemoglobin electrophoresis.
• Renal dysfunction: Elevated blood urea or creatinine, if included in extended profiles.
• Atypical red blood cell antibodies: Via indirect Coombs test that could cause hemolytic disease of the fetus.
• Maternal nutritional deficiencies: Affecting fetal bone development (such as severe Vitamin D deficiency, if co-ordered).
• Hepatic dysfunction: Or gestational cholestasis via abnormal liver enzymes, if clinically indicated.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Laboratory & Diagnostic Centre, we understand that pregnancy can be an anxious time for expectant parents, which is why we prioritize rapid, highly accurate reporting. The turnaround time for a standard Antenatal Screening Profile is typically within 12 to 24 hours from the time of sample collection. Our fully automated laboratory systems and integrated Laboratory Information Management System (LIMS) ensure that results are verified by qualified consultant pathologists and uploaded promptly.

Patients can access their diagnostic reports conveniently through multiple digital channels. You can download your reports directly from the official Dr. Essa Lab website by entering your patient ID and password provided on the receipt. Additionally, reports can be received via our dedicated WhatsApp service or through the Dr. Essa Lab mobile application. For those who prefer physical copies, printed reports can be collected from any of our numerous diagnostic centers across Karachi and other major cities in Pakistan.

Antenatal Screening Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Hemoglobin & Hematocrit	Normal maternal levels (Hb > 11.0 g/dL)	Low levels indicating iron deficiency or gestational anemia.
Blood Group & Rh Factor	Rh-Positive (no risk of Rh sensitization)	Rh-Negative (risk of maternal sensitization and hemolytic disease of the newborn).
Fasting Blood Glucose	< 95 mg/dL	Elevated levels indicating gestational diabetes or pre-existing impaired glucose tolerance.
Hepatitis B Surface Antigen (HBsAg)	Non-reactive / Negative	Reactive / Positive, indicating active Hepatitis B infection and risk of vertical transmission.
HIV I & II Antibodies	Non-reactive / Negative	Reactive / Positive, requiring immediate antiretroviral therapy to protect the fetus.
Syphilis Screen (VDRL/RPR)	Non-reactive / Negative	Reactive, indicating active or past syphilis infection requiring penicillin therapy.
Rubella IgG Antibodies	Positive (indicates protective immunity)	Negative (indicates susceptibility to congenital rubella syndrome; vaccination required postpartum).
Urine Protein	Negative to Trace	Elevated protein (Proteinuria), indicating potential pre-eclampsia or renal pathology.
Urine Bacteria & Leukocytes	Negative / None detected	Presence of bacteria, nitrites, or elevated WBCs, indicating a urinary tract infection (UTI).
Thyroid Stimulating Hormone (TSH)	Within pregnancy-specific reference ranges	Elevated (hypothyroidism) or suppressed (hyperthyroidism), affecting fetal development.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for Antenatal Screening?

• ISO 15189 Certified Laboratories: Dr. Essa Lab maintains international quality standards, ensuring the highest level of accuracy and reliability for all maternal screening tests.
• Experienced Consultant Pathologists: Our team of highly qualified clinical pathologists and microbiologists meticulously reviews and validates every antenatal report.
• State-of-the-Art Automated Technology: We utilize advanced, fully automated chemiluminescence and hematology analyzers to eliminate manual errors and deliver precise results.
• Convenient Home Sample Collection: Expectant mothers can avoid travel stress by utilizing our professional, sterile home sample collection service across Karachi.
• Rapid Turnaround Times: We understand the urgency of prenatal care, delivering comprehensive antenatal screening reports within 12 to 24 hours.
• Seamless Digital Access: Patients can easily view, download, and share their reports online via our website, mobile app, or dedicated WhatsApp service.
• Extensive Network of Branches: With numerous diagnostic centers conveniently located throughout Karachi and Pakistan, accessing our services is simple and hassle-free.
• Compassionate Patient Care: Our staff is specially trained to provide gentle, empathetic, and professional care to pregnant patients, ensuring a comfortable diagnostic experience.